BENGALURU Shares of India's Gland Pharma got off to a flying start in their market debut on Friday, rising as much as 23% and highlighting a strong appetite for drug stocks.
BENGALURU, Nov 17 Indian shares opened at record
highs on Tuesday, playing catch-up with overseas gains after a
long holiday weekend and bolstered by news that U.S. drugmaker
Moderna Inc's coronavirus vaccine was 94.5% effective in
BENGALURU Demand for COVID-19 antiviral drug remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts remain divided over its effectiveness.
BENGALURU, Oct 28 Drugmaker Dr Reddy's
Laboratories Ltd on Wednesday rolled out a preliminary
timeline for the India trials of Russia's coronavirus vaccine
candidate, with the late-stage expected to be completed by as
early as March 2021.
BENGALURU Drugmaker Dr Reddy's Laboratories Ltd on Wednesday rolled out a preliminary timeline for the India trials of Russia's coronavirus vaccine candidate, with the late-stage expected to be completed by as early as March 2021.
BENGALURU India's Bharat Biotech is in discussions with more than 10 countries that have shown an interest in a potential COVID-19 vaccine it is developing with a government agency, a company executive told Reuters on Friday.
BENGALURU Intensive care units (ICUs) at hospitals treating COVID-19 patients should do away with air-conditioning to limit the risk of infecting doctors, a study from a top Indian research institute has said.
BENGALURU/NEW DELHI India's death toll from the novel coronavirus rose past 100,000 on Saturday, only the third country in the world to reach that bleak milestone, after the United States and Brazil, and its epidemic shows no sign of abating. | Video
BENGALURU, Sept 18 Indian shares rose on Friday,
boosted by pharma stocks after Dr.Reddy's hit a record high, and
as broader Asian markets gained on hopes of more monetary
support from central banks.
BENGALURU, Sept 17 Indian shares fell on
Thursday, dragged down by banking stocks, as China tensions
remained in focus and after global markets gave up gains despite
the U.S. Federal Reserve saying it would keep interest rates